Market Research Logo

Europe Companion Diagnostics Market Forecast 2018-2026

Europe Companion Diagnostics Market Forecast 2018-2026
KEY FINDINGS

High demand for target therapy and growing efforts to develop advanced companion diagnostics tests are factors that are driving growth in the Europe companion diagnostics market. Over the forecast period of 2018-2026, the Europe companion diagnostic market is expected to register a CAGR of 18.17%.

MARKET INSIGHTS

Germany and the UK are the key revenue-generating markets in this region. The UK has established a ‘Precision Medicine Catapult’ initiative to accelerate the development of precision medicine in Europe. On the same line, booming pharmaceutical research and development is expected to fuel the research industry in Germany, further paving the way for the companion diagnostics market. Other geographies analyzed for this market include France, Spain, Italy and the rest of Europe. The market’s increased focused on implementing companion diagnostics due to rising new indication areas is expected to present profitable opportunities for several companion diagnostics providing companies in the region.

COMPETITIVE INSIGHTS

Sysmex Corporation, Thermo Fisher Scientific Inc, Illumina Inc, Roche Diagnostics (A Hoffmann-La Roche Ag Divison), Abbott Laboratories, Biocartis, Biomerieux S.A, Ge Healthcare, Danaher Corporation, Genomic Health, Almac Group, Qiagen N.V, and Myriad Genetics Inc are few of the noted companies in this market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Oncology Market To Hold The Largest Market Share In Terms Of Indicator
3.2.2. Assay Kits And Reagents Are Significantly Used In Terms Of Product And Service
3.2.3. Increasing Cancer Incidence In Europe
3.2.4. Next Generation Sequencing Growing Significantly
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Demand For Targeted Therapy
4.1.2. Increasing Prevalence Of Cancer
4.1.3. Swelling Strategic Initiatives For Companion Diagnostics Test Development
4.2. Market Restraints
4.2.1. Issues Related To Intellectual Property Rights
4.2.2. Reimbursement Issues
4.3. Market Opportunity
4.3.1. Focused On Implementing Companion Diagnostics Due To Rising New Indication Areas
4.3.2. Growing Demand For Next-generation Sequencing
4.3.3. Escalating Number Of Clinical Trials In Companion Diagnostics
4.4. Market Challenges
4.4.1. Prolonged Development Time Of Companion Diagnostics
4.4.2. Lengthy Approval Process
5. Market Segmentation
5.1. Market By Products And Services 2018-2026
5.1.1. Assay Kits And Reagents
5.1.2. Software And Service
5.2. Market By Indication 2018-2026
5.2.1. Oncology
5.2.2. Neurology
5.2.3. Infectious Diseases
5.2.4. Other Indications
5.3. Market By End User 2018-2026
5.3.1. Pharmaceutical And Biopharmaceutical Companies
5.3.2. Reference Laboratories
5.3.3. Other End Users
5.4. Market By Technology 2018-2026
5.4.1. In Situ Hybridization
5.4.2. Polymerase Chain Reaction
5.4.3. Immunohistochemistry
5.4.4. Next Generation Sequencing
5.4.5. Other Technologies
6. Key Analytics
6.1. Porter’s 5 Force Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Etymology Of Companion Diagnostics
6.3. Supply Chain Analysis
6.4. Key Buying Criteria
6.5. Regulatory Framework
6.6. Estimation Analysis
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Italy
7.1.6. Rest Of Europe
8. Company Profiles
8.1. Competitive Landscape
8.2. Abbott Laboratories.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Almac Group
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Arup Laboratories
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.5. Biocartis
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Biomerieux S.A
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.7. Danaher Corporation
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Ge Healthcare
8.8.1. Company Overview
8.8.2. Products Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Genomic Health
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc.
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Myriad Genetics, Inc.
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Qiagen N.V.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Roche Diagnostics (A Hoffmann-la Roche Ag Divison)
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Sysmex Corporation
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Thermo Fisher Scientific, Inc.
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table 1 Europe Companion Diagnostics Market 2018-2026 ($ Million)
Table 2 Europe Companion Diagnostics Market By Product And Service 2018-2026 ($ Million)
Table 3 Europe Companion Diagnostics Market In Assay Kits And Reagents 2018-2026 ($ Million)
Table 4 Europe Companion Diagnostics Market In Software And Service 2018-2026 ($ Million)
Table 5 Europe Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 6 Europe Companion Diagnostics Market In Oncology 2018-2026 ($ Million)
Table 7 Europe Companion Diagnostics Market In Neurology 2018-2026 ($ Million)
Table 8 Europe Companion Diagnostics Market In Infectious Diseases 2018-2026 ($ Million)
Table 9 Europe Companion Diagnostics Market In Other Indications 2018-2026 ($ Million)
Table 10 Europe Companion Diagnostics Market By End User 2018-2026 ($ Million)
Table 11 Europe Companion Diagnostics Market In Pharmaceutical And Biopharmaceutical Companies 2018-2026 ($ Million)
Table 12 Europe Companion Diagnostics Market In Reference Laboratories 2018-2026 ($ Million)
Table 13 Europe Companion Diagnostics Market In Other End Users 2018-2026 ($ Million)
Table 14 Europe Companion Diagnostics Market By Technology 2018-2026 ($ Million)
Table 15 Europe Companion Diagnostics Market In In Situ Hybridization 2018-2026 ($ Million)
Table 16 Europe Companion Diagnostics Market In Polymerase Chain Reaction 2018-2026 ($ Million)
Table 17 Europe Companion Diagnostics Market In Immunohistochemistry 2018-2026 ($ Million)
Table 18 Europe Companion Diagnostics Market In Next Generation Sequencing 2018-2026 ($ Million)
Table 19 Europe Companion Diagnostics Market In Other Technologies 2018-2026 ($ Million)
Table 20 Europe Companion Diagnostics Market By Countries 2018-2026 ($ Million)
Table 21 The United Kingdom Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 22 France Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 23 Germany Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 24 Spain Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Figure List
Figure 1 Europe Companion Diagnostics Market 2018-2026 ($ Million)
Figure 2 Growing Number Of People With Cancer Worldwide
Figure 3 Supply Chain Analysis Of Companion Diagnostics Industry
Figure 4 Key Buying Criteria
Figure 5 Newly Registered Clinical Trial Study 2016-2018
Figure 6 The United Kingdom Companion Diagnostics Market 2018-2026 ($ Million)
Figure 7 France Companion Diagnostics Market 2018-2026 ($ Million)
Figure 8 Germany Companion Diagnostics Market 2018-2026 ($ Million)
Figure 9 Spain Companion Diagnostics Market 2018-2026 ($ Million)
Figure 10 Italy Companion Diagnostics Market 2018-2026 ($ Million)
Figure 11 Rest Of Europe Companion Diagnostics Market 2018-2026 ($ Million)
Figure 12 Company Market Share Of Europe Companion Diagnostics Market 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report